BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25591759)

  • 21. Disruption of the TSLP-TSLPR-LAP signaling between epithelial and dendritic cells through hyperlipidemia contributes to regulatory T-Cell defects in atherosclerotic mice.
    Yu K; Dong Q; Mao X; Meng K; Zhao X; Ji Q; Wu B; Zhong Y; Zhu Z; Liu Y; Zhang W; Tony H; Shi H; Zeng Q
    Atherosclerosis; 2015 Feb; 238(2):278-88. PubMed ID: 25544178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.
    Branchford BR; Stalker TJ; Law L; Acevedo G; Sather S; Brzezinski C; Wilson KM; Minson K; Lee-Sherick AB; Davizon-Castillo P; Ng C; Zhang W; Neeves KB; Lentz SR; Wang X; Frye SV; Shelton Earp H; DeRyckere D; Brass LF; Graham DK; Di Paola JA
    J Thromb Haemost; 2018 Feb; 16(2):352-363. PubMed ID: 29045015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoinositide 3-kinase inhibition spares actin assembly in activating platelets but reverses platelet aggregation.
    Kovacsovics TJ; Bachelot C; Toker A; Vlahos CJ; Duckworth B; Cantley LC; Hartwig JH
    J Biol Chem; 1995 May; 270(19):11358-66. PubMed ID: 7744773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of PI3K/Akt signaling pathway in non-physiological shear stress-induced platelet activation.
    Chen Z; Li T; Kareem K; Tran D; Griffith BP; Wu ZJ
    Artif Organs; 2019 Sep; 43(9):897-908. PubMed ID: 30972780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qihuang Zhuyu formula alleviates coronary microthrombosis by inhibiting PI3K/Akt/αIIbβ3-mediated platelet activation.
    Ding Y; Xiang Q; Zhu P; Fan M; Tong H; Wang M; Cheng S; Yu P; Shi H; Zhang H; Chen X
    Phytomedicine; 2024 Mar; 125():155276. PubMed ID: 38295661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDF-15 prevents platelet integrin activation and thrombus formation.
    Rossaint J; Vestweber D; Zarbock A
    J Thromb Haemost; 2013 Feb; 11(2):335-44. PubMed ID: 23231375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling.
    Irfan M; Jeong D; Saba E; Kwon HW; Shin JH; Jeon BR; Kim S; Kim SD; Lee DH; Nah SY; Rhee MH
    Platelets; 2019; 30(5):589-598. PubMed ID: 29870296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrin αIIb-mediated PI3K/Akt activation in platelets.
    Niu H; Chen X; Gruppo RA; Li D; Wang Y; Zhang L; Wang K; Chai W; Sun Y; Ding Z; Gartner TK; Liu J
    PLoS One; 2012; 7(10):e47356. PubMed ID: 23082158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine allergic rhinitis and nasal Th2 activation are mediated via TSLP- and IL-33-signaling pathways.
    Akasaki S; Matsushita K; Kato Y; Fukuoka A; Iwasaki N; Nakahira M; Fujieda S; Yasuda K; Yoshimoto T
    Int Immunol; 2016 Feb; 28(2):65-76. PubMed ID: 26428949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct interaction of kindlin-3 with integrin αIIbβ3 in platelets is required for supporting arterial thrombosis in mice.
    Xu Z; Chen X; Zhi H; Gao J; Bialkowska K; Byzova TV; Pluskota E; White GC; Liu J; Plow EF; Ma YQ
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1961-7. PubMed ID: 24969775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ROS Promote Ox-LDL-Induced Platelet Activation by Up-Regulating Autophagy Through the Inhibition of the PI3K/AKT/mTOR Pathway.
    Wang X; Fu YF; Liu X; Feng G; Xiong D; Mu GF; Chen FP
    Cell Physiol Biochem; 2018; 50(5):1779-1793. PubMed ID: 30384368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo.
    Lin KH; Kuo JR; Lu WJ; Chung CL; Chou DS; Huang SY; Lee HC; Sheu JR
    Biochem Pharmacol; 2013 May; 85(10):1478-85. PubMed ID: 23473801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation.
    Blair TA; Moore SF; Walsh TG; Hutchinson JL; Durrant TN; Anderson KE; Poole AW; Hers I
    Cell Signal; 2018 Oct; 50():111-120. PubMed ID: 29793021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway.
    Hadas K; Randriamboavonjy V; Elgheznawy A; Mann A; Fleming I
    PLoS One; 2013; 8(9):e74401. PubMed ID: 24058557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
    Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL12 regulates platelet activation via the regulator of G-protein signaling 16.
    Karim ZA; Alshbool FZ; Vemana HP; Conlon C; Druey KM; Khasawneh FT
    Biochim Biophys Acta; 2016 Feb; 1863(2):314-21. PubMed ID: 26628381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β.
    O'Brien KA; Gartner TK; Hay N; Du X
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2232-40. PubMed ID: 22814751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymic stromal lymphopoietin contributes to myeloid hyperplasia and increased immunoglobulins, but not epidermal hyperplasia, in RabGEF1-deficient mice.
    Tsai M; Chen CC; Mukai K; Song CH; Thompson LJ; Ziegler SF; Tam SY; Galli SJ
    Am J Pathol; 2010 Nov; 177(5):2411-20. PubMed ID: 20829437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eisenia bicyclis (brown alga) modulates platelet function and inhibits thrombus formation via impaired P
    Irfan M; Kwon TH; Yun BS; Park NH; Rhee MH
    Phytomedicine; 2018 Feb; 40():79-87. PubMed ID: 29496178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic stromal lymphopoietin is a key cytokine for the immunomodulation of atherogenesis with Freund's adjuvant.
    Steinmetz M; Laurans L; Nordsiek S; Weiß L; van der Veken B; Ponnuswamy P; Esposito B; Vandestienne M; Giraud A; Göbbel C; Steffen E; Radecke T; Potteaux S; Nickenig G; Rassaf T; Tedgui A; Mallat Z
    J Cell Mol Med; 2020 May; 24(10):5731-5739. PubMed ID: 32285594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.